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Abstract
Background: The methylenetetrahydrofolate reductase (MTHFR) enzyme catalyzes the reduction of 5, 10-
methylenetetrahydrofolate to 5-methyltetrahydrofolate and methyl donors. The methyl donors are required for the
conversion of homocysteine to methionine. Mutation of MTHFR 677 C > T disrupts its thermostability therefore
leads to defective enzyme activities and dysregulation of homocysteine levels.
Methods: This case-control study (n = 367) was conducted to investigate the correlation of the MTHFR gene
polymorphism [NM_005957] and psoriasis vulgaris amongst the Malaysian population. Overnight fasting blood
samples were collected from a subgroup of consented psoriasis vulgaris patients and matched controls (n = 84) for
the quantification of homocysteine, vitamin B12 and folic acid levels.
Results: There was no significant increase of the MTHFR 677 C > T mutation in patients with psoriasis vulgaris
compared with controls (c
2 = 0.733, p = 0.392). No significant association between homocysteine levels and
MTHFR gene polymorphism in cases and controls were observed (F = 0.91, df = 3, 80, p = 0.44). However,
homocysteine levels in cases were negatively correlated with vitamin B12 (r = -0.173) and folic acid (r = -0.345)
levels. Vitamin B12 and folic acid levels in cases were also negatively correlated (r = -0.164).
Conclusions: Our results indicate that there was no significant association between the MTHFR gene
polymorphism and psoriasis vulgaris in the Malaysian population. There was no significant increase of the plasma
homocysteine level in the psoriasis patients compared to the controls.
Background
Psoriasis vulgaris also known as chronic plaque psoria-
sis, is a common subtype of psoriasis that affects about
80% of psoriatic patients worldwide [1]. Psoriasis has a
prevalence of 1-2% worldwide and it affects both sexes
equally [2]. The incidence in Malaysia is about 2.15%
[3]. Till date, the exact pathogenesis of this disease is
still unclear. Many different postulated aetiological
hypotheses have been forwarded to explain the patho-
genesis of the disease, yet the more convincing evi-
dences are being the genetic, environmental and
immunological factors [4]. However, in the last two dec-
ades, the association between methylenetetrahydrofolate
reductase (MTHFR) gene polymorphism and psoriasis
vulgaris has attracted great interest amongst researchers
worldwide. The contradicting results obtained from dif-
ferent studies conducted in the West and the Far East
had further confounded the situation [5-7].
The MTHFR gene (NM_005957) is located at chro-
mosome 1 (1p36.3). It catalyses the conversion of 5,10-
methylenetetrahydrofolate to 5-methylenetetra-hydrofo-
late, which then leads to the remethylation of homocys-
teine to methionine [8,9]. This cycle is important for
maintaining the methyl donors for DNA methylation,
and hence gene regulation and cellular differentiation
[5,10]. Polymorphism of the MTHFR gene involves the
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which leads to transition of Alanine to Valine. This
reduces MTHFR enzymatic activity and thermostability,
therefore interferes with the homocysteine levels [11,12].
The enzymatic remethylations of homocysteine to
methionine by 5-methyltetrahydrofolate homocysteine
methyltransferase rely heavily on the adequate levels of
vitamin B12 and folic acid. Therefore, the deficiencies of
the Vitamin B12 and folic acid will lead to hyperhomo-
cysteinaemia and hypomethioninaemia [13-16].
MTHFR gene polymorphism has been reported to be
associated with psoriasis vulgaris. Significant association
of the polymorphism of the MTHFR gene and psoriasis
vulgaris was reported in the Chinese population by
Wang et al., 2000 [5]. This Chinese study was later
refuted by the Austrian and the Czech study [6,7] on
the Caucasian population. Therefore, we hypothesize
that the MTHFR gene polymorphism 677 C > T was
associated with psoriasis vulgaris in the Asian popula-
tion and we tested our hypothesis on 200 Malaysian
psoriasis vulgaris patients.
Recent studies also postulated hyperhomocysteinaemia
as a risk factor for coronary heart disease, cerebrovascu-
lar accident and peripheral vascular diseases [17]. An
increase in 5 μmol/L of homocysteine level was asso-
ciated with significant increase risk of ischaemic heart
disease, thromboembolism and stroke. A reduction of
homocysteine level by 3 μmol/L with folic acid supple-
mentation could reduce the risk significantly [18].
However to date, there is no other study that we are
aware of which investigate the polymorphism of the
M T H F Rg e n ea n dp s o r i a s i sv u l g a r i so no t h e re t h n i c
groups of the Asian origin. We hypothesized that the
functional polymorphism of the MTHFR gene might be
associated with psoriasis vulgaris and hyperhomocystei-
naemia. The purpose of this hospital-based case-control
study was to determine the association of the MTHFR
gene polymorphism and psoriasis vulgaris in the Malay-
sian population which comprises of the 3 major Asian
populations: the Chinese, Indian and Malay ethnicities.
This study also aim to investigate whether MTHFR 677
C > T polymorphism might play a role in the homocys-
teine level of the psoriasis vulgaris patients from
Malaysia.
Methods
Study Population
The cases and controls were recruited from General
Hospital Kuala Lumpur and Tuanku Ja’afar Hospital,
Seremban, Malaysia from April 2009 to April 2010. All
the psoriasis vulgaris patients, cases (n = 200) recruited
were Malaysian with either Chinese, Indian or Malay
ethnicity. The patients with psoriasis vulgaris were
examined and diagnosed by the dermatologists based on
clinical examination. The severity of the disease was
then scored according to Psoriasis Area and Severity
Index (PASI). A mixture of early and late onset of psor-
i a s i sv u l g a r i sp a t i e n t sw a si n c l u d e di nt h i ss t u d y( m e a n
age 45.12 ± 14.20). The healthy controls (n = 167) were
those without psoriasis vulgaris and were age- (± 5
years), gender- and ethnicity-matched with the respec-
tive patients. The samples were determined based on
the criteria of 95% confidence and 85% statistical power
in determining the confidence intervals of the para-
meters estimated in this study. The patients and con-
trols were well informed about the nature of this study
and their participations were voluntary. Informed con-
sent was obtained from each subject. Approximately 5
mL of blood samples were withdrawn from each case or
control. A subgroup (n = 41) of consented patients with
homozygous CC, heterozygous CT and homozygous TT
genotypes were subsequently selected or recruited for
further study. Among the cases recruited (n = 200), only
41 cases consented for the subsequent skin biopsy pro-
cedure. The age- (± 5 years), gender- and ethnicity-
matched healthy controls (n = 43) were those with
homozygous CC, heterozygous CT and homozygous TT
genotypes but without psoriasis vulgaris. Their blood
samples were collected for the measurement of plasma
homocysteine, vitamin B12 and folic acid levels after
fasting for ~ 8 hours. Cases and controls with previous
history of ischaemic heart disease, myocardial infarction,
cerebrovascular accident, thromboembolic events were
excluded from this study. The blood samples were sent
to a commercial laboratory (Pathlab Malaysia Sdn Bhd)
for the measurement of homocysteine, vitamin B12 and
folate levels. The protocol of this study was designed
according to the Declaration of Helsinki and was
approved by the ethics committee of the International
Medical University, Malaysia.
Genotyping
DNA samples were extracted from the whole blood of
the cases and controls using DNA extraction kit (Qiagen
Inc, Germany) according to the manufacturer’s protocol.
The amount of the DNA was quantified and the quality
of the DNA was determined. The MTHFR gene was
amplified in a final volume of 25 μL using the following
primers: 5’-GAA GCA GGG AGC TTT GAG GC-3’
and 5’-CCC ATG TCG GTG CAT GCC TT-3’ [5]. For
each reaction, 12.5 μL of TopTaq master mix was used.
Both forward (0.25 μL) and reverse (0.25 μL) primers
were added. Finally, 2 μLo ft h ee x t r a c t e dD N Aw a s
added into the mixture. PCR was performed under the
following conditions: initial denaturation (3 minutes at
94°C), followed by a 3-step cycling processes (35 cycles)
which consisted of denaturation (30 seconds at 94°C),
annealing (30 seconds at 60°C) and extension (1 minute
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The final PCR product was 134 bp. The PCR products
were digested with restriction enzyme Taqa1 (New Eng-
land Biolabs, USA) and the digested products were sepa-
rated, and visualized on 12% polyacrylamide gels using a
BioVision 1000 gel documentation system (Vilber Lour-
mat, France). The typical polymerase chain reaction -
restriction fragment length polymorphism (PCR-RFLP)
was shown in Figure 1. The expected fragment sizes for
the polymorphism are 59 bp and 76 bp. The DNA
sequencing analysis of the MTHFR PCR amplified pro-
ducts (NM005957, rs1801133) were shown in Figure 2.
Statistical Analysis
The association between the genotypes of the MTHFR
polymorphism and allelic frequencies with the demo-
graphic variables was analyzed with Chi-square test. T-
test was used to determine the association of homocys-
teine, vitamin B12 and folic acid levels between cases
and controls irregardless of the genotypes. The associa-
tion between the plasma homocysteine, vitamin B12 and
folic acid levels and the MTHFR polymorphisms were
analyzed using 3-way ANOVA. P values were considered
statistically significant if they were less than 0.05. The
sample size was determined using the power analysis,
with the a error and b error set at 0.05 and 0.20 respec-
tively. Approximately 40 subjects per group were suffi-
cient for parametric test (Cohen, 1977) whilst for non-
parametric test such as Chi-Square test, the expected
frequency of a minimum 5 for each category was suffi-
cient (Hays, 1994). The measure of skewness and kurto-
sis were used to assess the normality of the distribution
of the parameters (homocysteine, vitamin B12 and folic
acid levels).
Results
Demography of the subjects
In this study, great attention was given to the selection
of the cases and the controls. The matching process was
conducted to ensure that the cases and controls have
similar demographic characteristics. Two hundred psor-
iasis vulgaris patients, diagnosed clinically by the derma-
tologists were age-, sex- and ethnicity- matched with
167 healthy controls. Table 1 showed the demographic
characteristics of the cases and controls. Cases and con-
trols with medical history of ischaemic heart disease,
cerebrovascular accident or thromboembolic events
were excluded from this study. Psoriatic Area and Sever-
ity Index (PASI) was performed on all psoriatic patients
upon recruitment.
T gene polymorphism in cases and
controls",1,0,1,0,0pc,0pc,0pc,0pc>MTHFR 677 C > T gene
polymorphism in cases and controls
The distribution of the MTHFR gene polymorphism
amongst cases and controls are shown in Table 2. Geno-
type CC was found in 79.50% of cases whilst 20.50%
were with genotype CT. As for the controls, 74.85% of
t h ec o n t r o l sw e r ew i t hg e n o t y p eC C ,2 3 . 9 5 %w e r ew i t h
genotype CT and 1.20% were with genotype TT. No sig-
nificant difference in the genotypic distribution between
cases and controls was observed (c
2 = 0.733, p = 0.392).
 
    
 100 bp 
  200 bp
  500 bp
-677 CT  -677 TT  -677 CC 
Figure 1 Polyacrylamide gel (12%) electrophoresis analysis of
the banding patterns of Taq-a1 digested MTHFR PCR-amplified
products.
A             B            C 
Figure 2 DNA sequencing analysis of the MTHFR PCR-amplified
products (NM_005957, rs1801133). Sequences of MTHFR 677 (A)
homozygous CC, (B) heterozygous CT, and (C) homozygous TT.
Table 1 Demographic characteristics of psoriasis vulgaris
cases and healthy controls
Demography Cases
(n = 200)
Controls
(n = 167)
Males, n (%) 113 (56.50) 87 (52.10)
Females, n (%) 87 (43.50) 80 (47.90)
Age, (mean ± SD) 45.12 ± 14.20 43.17 ± 14.66
PASI score (mean ± SD) 8.92 ± 7.64 N/A
Chinese, n (%) 39 (19.50) 33 (19.76)
Indian, n (%) 67 (33.50) 57 (34.13)
Malay, n (%) 94 (47.00) 77 (46.11)
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cases compared with controls (adjusted odds ratio (OR)
1.11; 95% confidence interval (CI) 0.47 - 2.60). However
this was not statistically significant (p = 0.812). The gen-
otype TT was not detected in the cases but was found
in two controls as such no further statistical analysis
was performed. The frequencies of distribution of the T
allele in cases and controls were comparable. No statisti-
cally significant difference in the frequency of allelic dis-
tribution between cases and controls was seen (c
2 =
1.52, p = 0.218).
The association between MTHFR gene polymorphism
(CC and CT) and ethnicities (Chinese, Malay and
Indian) was analyzed. The frequencies of the genotype
CT were significantly higher in the Malay population (p
< 0.002) in the cases compared with controls. The Chi-
square test for Goodness-of-Fit was used, since each cell
has an expected frequency of at least 5 subjects. Table 2
summarizes the genotype frequencies and the Chi-
square test results. Subjects with TT polymorphism
were not included since the numbers were too few.
Association between the plasma homocysteine, vitamin
B12 and folic acid levels in cases and controls
The plasma homocysteine, vitamin B12 and folic acid
levels of the selected cases (n = 41) and controls (n =
43) were summarized in Table 3. Homocysteine, vitamin
B12 and folic acid levels of cases regardless of the
MTHFR gene genotype were compared with the con-
trols. There was no significant difference between these
two groups on all the three parameters assessed with t-
test analysis (t = 0.955, p = 0.342 for homocysteine; t =
1.574, p = 0.119 for vitamin B; t = -0.745, p = 0.459 for
folic acid). The cases with genotype CT had the highest
homocysteine levels, followed by controls with genotype
CC, cases with genotype CC and controls with genotype
CT. No significant association between homocysteine
levels and MTHFR gene polymorphism in cases and
controls were seen (F = 0.91, df = 3, 80, p = 0.44). Simi-
larly, no significant association between vitamin B12
levels and MTHFR gene polymorphism in both cases
and controls was seen (F = 1.34, df = 3, 80, p = 0.27).
There was no significant association between folic acid
levels and MTHFR gene polymorphism in cases and
controls (F = 1.34, df = 3, 80, p = 0.27; Table 3).
The correlation between homocysteine, vitamin B12
and folic acid levels in cases and controls were deter-
mined. Homocysteine levels in cases were negatively
correlated with vitamin B12 (r = -0.173) and folic acid (r
= -0.345) levels. Similarly, vitamin B12 and folic acid
levels in cases were negatively correlated (r = -0.164).
Homocysteine levels in controls were negatively corre-
lated with vitamin B12 (r = -0.439) and folic acid (r =
-0.598) levels. However, vitamin B12 and folic acid levels
in controls were positively correlated (r = 0.250).
The homocysteine, vitamin B12 and folic acid levels in
cases and controls were summarized in Table 4 accord-
ing to gender and ethnicity. The associations of gender
and ethnicity with homocysteine, vitamin B12 and folic
acid levels were analyzed with Three Way ANOVA.
Gender was the only variable that was significantly asso-
ciated with homocysteine levels (F = 19.538, p = 0.000).
Males (mean = 17.00 and SD = 4.06) have significantly
(p = 0.001) higher homocysteine levels compared with
female (mean = 12.43 and SD = 3.10). It can be con-
cluded that plasma homocysteine levels were not asso-
ciated with psoriasis vulgaris, MTHFR gene
polymorphism and ethnicity.
As for vitamin B12, similar results were seen as of
homocysteine levels. Nonetheless vitamin B12 levels
were associated with gender.
Both cases and controls of the Chinese ethnicity had
significantly (p = 0.000) higher folic acid levels (mean =
11.51, SD = 6.10) compared with Indians (mean = 7.35,
SD = 4.92) and Malays (mean 6.10, SD = 2.37). How-
ever, folic acid levels in different ethnic groups were not
associated with gender (p = 0.062) and MTHFR gene (p
= 0.128).
Discussion
The association between MTHFR gene polymorphism
and psoriasis vulgaris was reported by Wang et al.
(2000) [5] and was refuted by the studies conducted in
Austria (Weger et al., 2008) [6] and the Czech Republic
Table 2 Distribution of cases and controls according to
races, genotypes and allelic frequencies of the MTHFR
gene
MTHFR C > T Cases
(n = 200)
Controls
(n = 167)
* P-value **OR (95% CI)
CC, n (%) 159 (79.50) 125 (74.85) p = 0.392 1.11 (0.47-2.60)
Chinese, n (%) 30 (18.87) 21 (16.80) c
2 = 0.733
Indian, n (%) 57 (35.85) 49 (39.20)
Malay, n (%) 72 (45.28) 55 (44.00)
CT, n (%) 41 (20.50) 40 (23.95)
Chinese, n (%) 9 (21.95) 11 (27.50)
Indian, n (%) 10 (24.39) 22 (55.00)
Malay, n (%) 22 (53.66) 7 (17.50)
TT, n (%) 0 (0.00) 2 (1.20)
Chinese, n (%) 0 (0.00) 1 (50.00)
Indian, n (%) 0 (0.00) 1 (50.00)
Malay, n (%) 0 (0.00) 0 (0.00)
ALLELE
C (%) 359 (89.75) 290 (86.83) p = 0.218
T (%) 41 (10.25) 44 (13.17) c
2 = 1.520
* P-values obtained for the c
2 test for the genotypes distribution or allelic
frequencies between cases and controls.
** OR is the risk of genotype CT in cases compared to controls
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were postulated to the probable differences in ethnici-
ties. Till date, no other report on the prevalence of this
MTHFR gene polymorphism and psoriasis vulgaris was
documented for the Asian population. The association
of the MTHFR gene polymorphism and psoriasis vul-
garis has been postulated due to the higher risk of psor-
iasis patients developing cardiovascular and
cerebrovascular complications. Nonetheless, the patho-
genesis is not known till date [5-7,17,18].
The association of the MTHFR gene polymorphism
and psoriasis vulgaris in the Malaysian population i.e.
Chinese, Indian and Malay ethnic groups was investi-
gated in this case-control hospital based study. Two
hundred patients and 167 controls were recruited. The
methodology of this study was conducted according to
Wang et al. (2000) [5]. Our results demonstrated that
there was no statistically significant association between
MTHFR C > T gene polymorphism and psoriasis vul-
garis in the Malaysian population, which consistent with
the Austrian [6] and the Czech Republic’s [7] findings
on Caucasian population. Our study thus contradicts
the published study in China [5]. Our study also investi-
gated the association of the MTHFR gene polymorphism
and ethnicities in Malaysia namely the Chinese, Indian
and Malay. We reported that there were no significant
association between MTHFR gene polymorphism in
psoriasis vulgaris and ethnicities in the Malaysian popu-
lation. Though a larger sample size of patients was
investigated in the present study, we did not find any
significant association of the MTHFR gene polymorph-
ism and psoriasis vulgaris as compared with the pre-
vious Chinese study on only 39 Chinese patients [5].
Table 3 Demographic distribution of cases and controls according to their genotypes and homocysteine, vitamin B12
and folic acid levels
Cases
(CC)
(n = 19)
Cases
(CT or TT)
(n = 22)
Controls
(CC)
(n = 21)
Controls
(CT or TT)
(n = 22)
*P-value
Males, n (%) 11 (42.10) 11 (50.00) 10 (47.60) 11 (50.00)
Chinese 3 (27.27) 3 (27.27) 2 (20.00) 2 (18.18)
Indian 2 (18.18) 2 (18.18) 2 (20.00) 4 (36.36)
Malay 6 (54.55) 6 (54.55) 6 (60.00) 5 (45.45)
Females, n (%) 8 (42.10) 11 (50.00) 11 (52.38) 11 (50.00)
Chinese 2 (25.00) 3 (27.27) 3 (27.27) 4 (36.36)
Indian 3 (37.50) 5 (45.45) 5 (45.45) 4 (36.36)
Malay 3 (37.50) 3 (27.27) 3 (27.27) 3 (27.27)
Age, mean ± SD 38.41 ± 12.36 45.91 ± 13.17 43.43 ± 11.93 43.64 ± 10.84
PASI score,
mean ± SD
9.22 ± 10.85 6.37 ± 4.97 N/A N/A
Homocysteine (μmol/L) 14.92 ± 4.13 16.31 ± 4.56 15.42 ± 3.81 14.39 ± 3.59 [p = 0.440]
Vitamin B12 (pg/mL) 482.22 ± 156.98 465.84 ± 210.73 396.38 ± 96.06 444.20 ± 112.19 [p = 0.270]
Folic acid (ng/mL) 7.66 ± 3.91 7.24 ± 4.61 6.62 ± 3.19 9.14 ± 6.40 [p = 0.270]
* P-values obtained for the F-test for the homocysteine, vitamin B12 and folic acid levels in cases and controls with different genotypes.
Table 4 Homocysteine, vitamin B12, and folic acid levels
for cases and controls according to gender and
ethnicities
Cases
(CC)
(n = 19)
Cases
(CT or TT)
(n = 22)
Controls
(CC)
(n = 21)
Controls
(CT or TT)
(n = 22)
Homocysteine, (Normal reference value = 5.0-15.0 μmol/L)
Males, mean (μmol/L)
Chinese 14.97 17.67 13.68 12.25
Indian 13.25 19.85 19.50 16.13
Malay 18.05 17.80 15.85 16.66
Females
Chinese 12.35 13.20 13.80 13.55
Indian 13.47 16.28 13.14 13.15
Malay 13.23 12.77 12.40 11.93
Vitamin B12, (Normal reference value = 211-911 pg/mL)
Males, mean (pg/mL)
Chinese 495.0 271.5 271.5 483.5
Indian 630.5 315.0 317.0 373.3
Malay 410.8 562.7 431.5 485.0
Females
Chinese 385.0 386.3 478.0 420.7
Indian 452.0 386.0 414.4 420.0
Malay 620.7 625.3 350.7 513.0
Folic acid, (Normal reference value = > 2.8 ng/mL)
Males, mean (ng/mL)
Chinese 11.8 14.9 5.2 14.1
Indian 7.5 6.1 3.6 10.5
Malay 4.7 5.5 6.0 5.7
Females
Chinese 11.5 24.0 12.5 11.3
Indian 12.5 9.0 13.4 7.8
Malay 6.1 7.1 7.5 13.8
Liew et al. Nutrition Journal 2012, 11:1
http://www.nutritionj.com/content/11/1/1
Page 5 of 7T h ep r e v a l e n c eo ft h eM T H F R6 7 7C>Ti sv a r i a b l e
depending on the geography and ethnicity [19]. Botto et
al. (2000) reported that the worldwide T allele frequency
was highest in the Italian and the Hispanics, and lowest
in the American Blacks and sub-saharan Africa. In the
European population, the distribution of the homozy-
gous T allele was highest in the Italian and lowest in the
German [20-22]. In the Blacks, the frequency of T
homozygosity in the sub-Saharan African population
showed zero percentage [23,24]. In Asian, limited data
could be retrieved as only the Japanese population was
studied and the population percentage of the homozy-
gous T mutation was 11% [25,26]. An interesting finding
that we discovered in this study was the homozygosity
of the T genotypes was found only in 2 of the controls
but not in the cases. This finding contradicted the Chi-
nese study [5] which reported the significant increased
of homozygous TT in the cases compared with controls
(p < 0.05). We hypothesized this variation may be due
to the geographical differences as seen in the Europeans
[27].
The MTHFR gene polymorphism was reported to be
associated with hyperhomocysteinaemia which has dele-
terious effects on the cardiovascular system [13,28].
Hence, psoriasis vulgaris patients with MTHFR gene
polymorphism may be at greater risk of cardiovascular
diseases and thromboembolic events. Therefore, we
investigated the relationship between MTHFR gene
polymorphism and homocysteine, vitamin B12 and folic
acid levels in selected 41 cases and 43 controls. We
demonstrated that there was no significant relationship
between the MTHFR gene polymorphism and homocys-
teine, vitamin B12 or folic acid levels in this subset of
subjects.
The relationship of homocysteine, vitamin B12 and
folic acid levels compared with the ethnicities and the
MTHFR gene polymorphism was analyzed using 3-way
ANOVA. We did not find any statistically significant
relationship amongst these groups. Nonetheless, males
irregardless of the polymorphism of the MTHFR gene
have a higher homocysteine levels when compared to
the females (p = 0.001). Overall, the Indian males and
Malay males have higher homocysteine levels than the
Chinese males and a significantly lower folic acid level
compared to the Chinese (p = 0.000).
In Malaysia, the dietary intakes varied amongst the
ethnic groups and also varied amongst the genders
[29,30]. The Indian and the Malay groups have a higher
intake of coconut oil, processed sugars and condensed
milk in their diet when compared to the Chinese. We
proposed that the significant increased in homocysteine
level in the Indian and Malay males might be due to the
different dietary intakes between different ethnic groups
amongst the males. The observation that the folic acid
level that is significantly higher in the Chinese again
pinpointed the beneficial effect of folic acid in the low-
ering of the plasma homocysteine level [12]. Therefore,
these differences might be a beneficial consideration to
be taken note of when other epidemiological studies are
being carried out in these populations in the future.
The limitation of this study was the centrality of the
recruitment of the subjects in the area of Kuala Lumpur
and Seremban and we did not recruit subjects from the
northern, eastern or southern states of Malaysia. Per-
h a p s ,t h e r ew o u l dh a v eb e e nad i f f e r e n c ei nt h eg e n o -
types distribution in these places compared with the
ones we have recruited. Future studies might be war-
ranted to investigate the variation of the MTHFR 677 C
> T gene geographically, perhaps on other Asian popu-
l a t i o n su s i n gab i g g e rs a m p l es i z ea n dal a r g e rp o p u l a -
tion. The inclusion of other single nucleotide
polymorphism of the MTHFR gene would be beneficial
to investigate the association of the presence of synergis-
tic effects of the haplotypes and psoriasis vulgaris.
This study has again pinpointed the independent
hyperhomocysteinaemia irrespective of the possession of
psoriasis vulgaris, mutation of the MTHFR gene and its
prevalence in the male gender. With the prior knowl-
edge of hyperhomocysteinaemia as a risk for cardiovas-
cular and thromboembolic events, routine homocysteine
and folic acid screening should be included as part of
psoriasis vulgaris and cardiovascular disease manage-
ment. The routine supplementation of folic acid in the
diet of the psoriasis vulgaris patients could be of benefit
to them.
Conclusions
In summary, we concluded that the MTHFR 677 C > T
gene polymorphism and the T allele occurrence were
not significantly associated with psoriasis vulgaris in the
Malaysian population. We also concluded that there was
no significant association between the plasma homocys-
t e i n el e v e l sa n dp s o r i a s i sv u l g a r i sw i t ho rw i t h o u tt h e
MTHFR gene polymorphism.
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